期刊文献+

文拉法辛缓释剂与速释剂治疗抑郁症对照研究 被引量:2

Comparative study of venlafaxine extended release and immediate release in treatment of depression
暂未订购
导出
摘要 目的:比较文拉法辛缓释剂(XR)与速释剂(IR)治疗抑郁症的疗效及不良反应。方法:对门诊及住院抑郁症患者60例随机分为两组,分别给予文拉法辛缓释剂或速释剂治疗12周。治疗前后给予汉密尔顿抑郁量表(HAMD)、汉密尔顿焦虑量表(HAMA)评定疗效,副反应量表(TESS)评定不良反应。结果:缓释剂组显效率为86.6%,速释剂组显效率为83.3%。治疗后HAMD和HAMA评分均有显著减少。结论:与速释剂相比,缓释剂能有效的缓解抑郁、焦虑症状,且有较好的耐受性和依从性。 Objective:To study the efficacy and side effects of venlafaxine extended release (XR) and venlafaxine immediate release (IR) in the treatment of depression. Method:Sixty depressed inpatients and outpatients were randomly divided into XR group or IR group for 12 weeks. Before and after treatment, all participants were examined with Hamilton depression scale (HAMD) and Hamilton anxiety scale (HAMA) to assess the efficacy. The side effects were assessed by treatment emergent symptoms scale (TESS), Results:The improvement rate of XR and IR was 86.6% and 83.3% respectively.The scores of HAMD and HAMA decreased significantly after treatment in both groups. Conclusion: Compared with IR, XR not only improves the symptoms of depression and anxiety, but also has good tolerance and compliance.
出处 《临床精神医学杂志》 2005年第4期216-217,共2页 Journal of Clinical Psychiatry
关键词 抑郁症 文拉法辛缓释剂 文拉法辛速释剂 depression venlafaxine extended release venlafaxine immediate release
  • 相关文献

参考文献4

二级参考文献22

  • 1田运华,王祖訢,顾牛范,施慎迅,黄明生,孙学礼,姚芳传,谢光荣,黄淑贞,秦英绂,许美庭.帕罗西汀与阿米替林治疗抑郁症的双盲对照研究[J].中华精神科杂志,1996,29(2):123-124. 被引量:4
  • 2[1]Montgomery SA.Rapid onset of action of venlafaxine.J Inter Clin Psychopharmacol,1995,(suppl 2):21
  • 3[2]Albert Derivan.Venlafaxine:measuring the onset of antidepressant action.J Psychopharmacol Bull,1995,2:439
  • 4施慎逊,张明园,陆峥,方贻儒,杨晓敏,盛尤荣,肖泽萍,田运华,秦英绂,黄淑珍,吉中孚,陈国强,许行建,张晋碚.氟西汀治疗抑郁症的多中心开放性对照研究[J].中华精神科杂志,1997,30(2):74-78. 被引量:45
  • 5Paykel E, Bamana R, Cooper Z, et al. Residual symptoms after partial remission: an important outcome in depression. Psycho Med,1995,25 : 1171-1180.
  • 6Thase ME, Entsuah AR, Rvdolph RL,et al. Remission rates during treatment with venlafaxine or SSRIs. Br J Psychiatry,2001,178:234-241.
  • 7Harvey AT, Rudolph RL, Preskorn SH. Evidence of the dual mechanisms of action of venlafaxine. Arch Gen Psychiatry, 2000,57:503-509.
  • 8Feighner JP. Overview of antidepressants currently used to treat anxiety disorders. J Clin Psychiatry, 1999,60 Suppl 2:18-22.
  • 9Ballus C, Quiros G, De Flores T, et al. The efficacy and tolerability of venlafaxine and paroxetine in outpatients with depressive or dysthymia, Int Clin Psychopharmacol, 2000, 15: 43-48.
  • 10Mehetonen OP, Belinke K, Sogaard J,et al. Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depression. J CAin Psychialry,2000, 61:95-100.

共引文献50

同被引文献9

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部